Alpha 2.0
Login Register
» Articles » PMID: 25660810

UK and US Governments to Fund Personalised Medicine

Overview
Journal Lancet Oncol
Specialty Oncology
Date 2015 Feb 10
PMID 25660810
Citations 3
Authors
Talha Burki
Affiliations
Soon will be listed here.
Citing Articles

Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.

Malla S, Byrne R, Lafarge M, Corry S, Fisher N, Tsantoulis P Nat Genet. 2024; 56(3):458-472.

PMID: 38351382 PMC: 10937375. DOI: 10.1038/s41588-024-01654-5.

Delivering a research-enabled multistakeholder partnership for enhanced patient care at a population level: The Northern Ireland Comprehensive Cancer Program.

Lawler M, Gavin A, Salto-Tellez M, Kennedy R, Van Schaeybroeck S, Wilson R Cancer. 2015; 122(5):664-73.

PMID: 26695702 PMC: 4864440. DOI: 10.1002/cncr.29814.

Changing the Paradigm—Multistage Multiarm Randomized Trials and Stratified Cancer Medicine.

Lawler M, Kaplan R, Wilson R, Maughan T Oncologist. 2015; 20(8):849-51.

PMID: 26070918 PMC: 4524758. DOI: 10.1634/theoncologist.2015-0014.